Differential role of EGF and bFGF in human GBM-TIC proliferation: Relationship to EGFR-tyrosine kinase inhibitor sensitivity

A. Bajetto, C. Porcile, A. Pattarozzi, L. Scotti, A. Aceto, A. Daga, F. Barbieri, T. Florio

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Glioblastoma multiforme (GBM) is among the most devastating human tumors being rapidly fatal despite aggressive surgery, radiation and chemotherapies. It is characterized by extensive dissemination of tumor cells within the brain that hinders complete surgical resection. GBM tumor initiating-cells (TICs) are a rare subpopulation of cells responsible for tumor development, growth, invasiveness and recurrence after chemotherapy. TICs from human GBM can be selected in vitro using the same conditions permissive for the growth of normal neural cells, of which share some features including marker expression, self-renewal capacity, long-term proliferation, and ability to differentiate into neuronal and glial cells. EGFR overexpression and its constitutive activation is one of the most important signaling alteration identified in GBM, and its pharmacological targeting represents an attractive therapeutic goal. We previously demonstrated that human GBM TICs have different sensitivity to the EGFR kinase inhibitors erlotinib and gefitinib, depending on the differential modulation of downstream signaling cascades. In this work we investigated the mechanisms of resistance to erlotinib in two human GBM TIC cultures, analyzing EGF and bFGF individual contribution to proliferation, clonogenicity, and migration. We demonstrated the presence of a small cell subpopulation whose proliferation is supported by EGF and a larger one mainly dependent on bFGF. Thus, insensitivity to EGFR kinase inhibitors as far as TIC proliferation results from a predominant FGFR activation that hides the inhibitory effects induced on EGFR signaling. Conversely, EGF and bFGF induced cell migration with similar efficacy. In addition, unlike neural stem/progenitors cells, the removal of chondroitin sulphate proteoglycans from cell surface was unable to discern EGF- and bFGF-dependent subpopulations in GBM TICs.

Original languageEnglish
Pages (from-to)143-154
Number of pages12
JournalJournal of Biological Regulators and Homeostatic Agents
Volume27
Issue number1
Publication statusPublished - 2013

Fingerprint

Neoplastic Stem Cells
Glioblastoma
Epidermal Growth Factor
Protein-Tyrosine Kinases
Cell Proliferation
Phosphotransferases
Chondroitin Sulfate Proteoglycans
Drug Therapy
Neoplasms
Neural Stem Cells
Growth and Development
Neuroglia
Cell Movement
Stem Cells
Cell Culture Techniques
Pharmacology
Radiation
Recurrence
Brain
Growth

Keywords

  • BFGF, tyrosine kinase inhibitors
  • Glioblastoma, tumor-initiating cells, EGF

ASJC Scopus subject areas

  • Oncology
  • Endocrinology, Diabetes and Metabolism
  • Physiology (medical)
  • Immunology and Allergy
  • Immunology
  • Endocrinology
  • Physiology
  • Cancer Research

Cite this

Differential role of EGF and bFGF in human GBM-TIC proliferation : Relationship to EGFR-tyrosine kinase inhibitor sensitivity. / Bajetto, A.; Porcile, C.; Pattarozzi, A.; Scotti, L.; Aceto, A.; Daga, A.; Barbieri, F.; Florio, T.

In: Journal of Biological Regulators and Homeostatic Agents, Vol. 27, No. 1, 2013, p. 143-154.

Research output: Contribution to journalArticle

Bajetto, A. ; Porcile, C. ; Pattarozzi, A. ; Scotti, L. ; Aceto, A. ; Daga, A. ; Barbieri, F. ; Florio, T. / Differential role of EGF and bFGF in human GBM-TIC proliferation : Relationship to EGFR-tyrosine kinase inhibitor sensitivity. In: Journal of Biological Regulators and Homeostatic Agents. 2013 ; Vol. 27, No. 1. pp. 143-154.
@article{ae222cc93648484d9a67ce6f594d0031,
title = "Differential role of EGF and bFGF in human GBM-TIC proliferation: Relationship to EGFR-tyrosine kinase inhibitor sensitivity",
abstract = "Glioblastoma multiforme (GBM) is among the most devastating human tumors being rapidly fatal despite aggressive surgery, radiation and chemotherapies. It is characterized by extensive dissemination of tumor cells within the brain that hinders complete surgical resection. GBM tumor initiating-cells (TICs) are a rare subpopulation of cells responsible for tumor development, growth, invasiveness and recurrence after chemotherapy. TICs from human GBM can be selected in vitro using the same conditions permissive for the growth of normal neural cells, of which share some features including marker expression, self-renewal capacity, long-term proliferation, and ability to differentiate into neuronal and glial cells. EGFR overexpression and its constitutive activation is one of the most important signaling alteration identified in GBM, and its pharmacological targeting represents an attractive therapeutic goal. We previously demonstrated that human GBM TICs have different sensitivity to the EGFR kinase inhibitors erlotinib and gefitinib, depending on the differential modulation of downstream signaling cascades. In this work we investigated the mechanisms of resistance to erlotinib in two human GBM TIC cultures, analyzing EGF and bFGF individual contribution to proliferation, clonogenicity, and migration. We demonstrated the presence of a small cell subpopulation whose proliferation is supported by EGF and a larger one mainly dependent on bFGF. Thus, insensitivity to EGFR kinase inhibitors as far as TIC proliferation results from a predominant FGFR activation that hides the inhibitory effects induced on EGFR signaling. Conversely, EGF and bFGF induced cell migration with similar efficacy. In addition, unlike neural stem/progenitors cells, the removal of chondroitin sulphate proteoglycans from cell surface was unable to discern EGF- and bFGF-dependent subpopulations in GBM TICs.",
keywords = "BFGF, tyrosine kinase inhibitors, Glioblastoma, tumor-initiating cells, EGF",
author = "A. Bajetto and C. Porcile and A. Pattarozzi and L. Scotti and A. Aceto and A. Daga and F. Barbieri and T. Florio",
year = "2013",
language = "English",
volume = "27",
pages = "143--154",
journal = "Journal of Biological Regulators and Homeostatic Agents",
issn = "0393-974X",
publisher = "Biolife s.a.s.",
number = "1",

}

TY - JOUR

T1 - Differential role of EGF and bFGF in human GBM-TIC proliferation

T2 - Relationship to EGFR-tyrosine kinase inhibitor sensitivity

AU - Bajetto, A.

AU - Porcile, C.

AU - Pattarozzi, A.

AU - Scotti, L.

AU - Aceto, A.

AU - Daga, A.

AU - Barbieri, F.

AU - Florio, T.

PY - 2013

Y1 - 2013

N2 - Glioblastoma multiforme (GBM) is among the most devastating human tumors being rapidly fatal despite aggressive surgery, radiation and chemotherapies. It is characterized by extensive dissemination of tumor cells within the brain that hinders complete surgical resection. GBM tumor initiating-cells (TICs) are a rare subpopulation of cells responsible for tumor development, growth, invasiveness and recurrence after chemotherapy. TICs from human GBM can be selected in vitro using the same conditions permissive for the growth of normal neural cells, of which share some features including marker expression, self-renewal capacity, long-term proliferation, and ability to differentiate into neuronal and glial cells. EGFR overexpression and its constitutive activation is one of the most important signaling alteration identified in GBM, and its pharmacological targeting represents an attractive therapeutic goal. We previously demonstrated that human GBM TICs have different sensitivity to the EGFR kinase inhibitors erlotinib and gefitinib, depending on the differential modulation of downstream signaling cascades. In this work we investigated the mechanisms of resistance to erlotinib in two human GBM TIC cultures, analyzing EGF and bFGF individual contribution to proliferation, clonogenicity, and migration. We demonstrated the presence of a small cell subpopulation whose proliferation is supported by EGF and a larger one mainly dependent on bFGF. Thus, insensitivity to EGFR kinase inhibitors as far as TIC proliferation results from a predominant FGFR activation that hides the inhibitory effects induced on EGFR signaling. Conversely, EGF and bFGF induced cell migration with similar efficacy. In addition, unlike neural stem/progenitors cells, the removal of chondroitin sulphate proteoglycans from cell surface was unable to discern EGF- and bFGF-dependent subpopulations in GBM TICs.

AB - Glioblastoma multiforme (GBM) is among the most devastating human tumors being rapidly fatal despite aggressive surgery, radiation and chemotherapies. It is characterized by extensive dissemination of tumor cells within the brain that hinders complete surgical resection. GBM tumor initiating-cells (TICs) are a rare subpopulation of cells responsible for tumor development, growth, invasiveness and recurrence after chemotherapy. TICs from human GBM can be selected in vitro using the same conditions permissive for the growth of normal neural cells, of which share some features including marker expression, self-renewal capacity, long-term proliferation, and ability to differentiate into neuronal and glial cells. EGFR overexpression and its constitutive activation is one of the most important signaling alteration identified in GBM, and its pharmacological targeting represents an attractive therapeutic goal. We previously demonstrated that human GBM TICs have different sensitivity to the EGFR kinase inhibitors erlotinib and gefitinib, depending on the differential modulation of downstream signaling cascades. In this work we investigated the mechanisms of resistance to erlotinib in two human GBM TIC cultures, analyzing EGF and bFGF individual contribution to proliferation, clonogenicity, and migration. We demonstrated the presence of a small cell subpopulation whose proliferation is supported by EGF and a larger one mainly dependent on bFGF. Thus, insensitivity to EGFR kinase inhibitors as far as TIC proliferation results from a predominant FGFR activation that hides the inhibitory effects induced on EGFR signaling. Conversely, EGF and bFGF induced cell migration with similar efficacy. In addition, unlike neural stem/progenitors cells, the removal of chondroitin sulphate proteoglycans from cell surface was unable to discern EGF- and bFGF-dependent subpopulations in GBM TICs.

KW - BFGF, tyrosine kinase inhibitors

KW - Glioblastoma, tumor-initiating cells, EGF

UR - http://www.scopus.com/inward/record.url?scp=84878806886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878806886&partnerID=8YFLogxK

M3 - Article

C2 - 23489694

AN - SCOPUS:84878806886

VL - 27

SP - 143

EP - 154

JO - Journal of Biological Regulators and Homeostatic Agents

JF - Journal of Biological Regulators and Homeostatic Agents

SN - 0393-974X

IS - 1

ER -